SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-14-001901
Filing Date
2014-05-30
Accepted
2014-05-30 08:00:53
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-3 zk1415018.htm F-3 917133
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 10256
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 17099
4 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 5106
5 logo.jpg GRAPHIC 11030
6 graph.jpg GRAPHIC 127530
7 yalogo.jpg GRAPHIC 13135
8 pwc.jpg GRAPHIC 5443
9 mofo.jpg GRAPHIC 3999
  Complete submission text file 0001178913-14-001901.txt   1173229
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-196390 | Film No.: 14877773
SIC: 2834 Pharmaceutical Preparations